Pri-Med Washington, D.C | March 2026

Wednesday−Thursday, March 18–19|Washington, DC

Pri-Med Washington, D.C. | Medical Conference

Thursday, March 19 2026

9:40–10:25am

Industry Theater

Learn About a PrEP Injectable Option

Industry Theater 1, Room 145AB, Level 1

Description

Explore the evidence of PrEP as a highly effective but underutilized HIV prevention strategy, including opportunities to further decrease HIV diagnoses, especially in underserved populations. Select details on clinical trial data for an injectable PrEP option and information about its use in clinical practice will also be examined.

Sponsored by

  • Gilead Sciences, Inc.